Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

MED17 anticorps (Middle Region)

MED17 Reactivité: Humain WB, EIA Hôte: Lapin Polyclonal unconjugated
N° du produit ABIN953370
  • Antigène Voir toutes MED17 Anticorps
    MED17 (Mediator Complex Subunit 17 (MED17))
    Épitope
    • 16
    • 9
    • 7
    • 6
    • 6
    • 6
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 331-361, Middle Region
    Reactivité
    • 51
    • 26
    • 6
    • 3
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    Humain
    Hôte
    • 51
    • 3
    Lapin
    Clonalité
    • 52
    • 2
    Polyclonal
    Conjugué
    • 25
    • 5
    • 4
    • 4
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp MED17 est non-conjugé
    Application
    • 48
    • 31
    • 14
    • 9
    • 5
    • 4
    • 2
    • 1
    Western Blotting (WB), Enzyme Immunoassay (EIA)
    Specificité
    This antibody recognizes Human MED17 (Center).
    Purification
    Protein A column, followed by peptide affinity purification
    Immunogène
    KLH conjugated synthetic peptide between 331-361 amino acids from the Central region of human MED17
    Isotype
    Ig Fraction
    Top Product
    Discover our top product MED17 Anticorps primaire
  • Indications d'application
    Optimal working dilution should be determined by the investigator.
    Restrictions
    For Research Use only
  • Format
    Liquid
    Concentration
    0.25 mg/mL
    Buffer
    PBS containing 0.09 % (W/V) Sodium Azide as preservative
    Agent conservateur
    Sodium azide
    Précaution d'utilisation
    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Conseil sur la manipulation
    Avoid repeated freezing and thawing.
    Stock
    4 °C/-20 °C
    Stockage commentaire
    Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
  • Antigène
    MED17 (Mediator Complex Subunit 17 (MED17))
    Autre désignation
    MED17 (MED17 Produits)
    Synonymes
    anticorps crsp6, anticorps CRSP6, anticorps CRSP77, anticorps DRIP80, anticorps TRAP80, anticorps 77kDa, anticorps C330002H14Rik, anticorps Crsp6, anticorps Trap80, anticorps mediator of RNA polymerase II transcription subunit 17, anticorps mediator complex subunit 17, anticorps mediator complex subunit 17 L homeolog, anticorps AOR_1_2446154, anticorps VDBG_01663, anticorps med17, anticorps med17.L, anticorps MED17, anticorps Med17
    Sujet
    The activation of gene transcription is a multistep process that is triggered by factors that recognize transcriptional enhancer sites in DNA. These factors work with co-activators to direct transcriptional initiation by the RNA polymerase II apparatus. The protein encoded by this gene is a subunit of the CRSP (cofactor required for SP1 activation) complex, which, along with TFIID, is required for efficient activation by SP1. This protein is also a component of other multisubunit complexes e.g. thyroid hormone receptor-(TR-) associated proteins which interact with TR and facilitate TR function on DNA templates in conjunction with initiation factors and cofactors.Synonyms: ARC77, Activator-recruited cofactor 77 kDa component, CRSP complex subunit 6, CRSP6, Cofactor required for Sp1 transcriptional activation subunit 6, DRIP77, DRIP80, Mediator complex subunit 17, Mediator of RNA polymerase II transcription subunit 17, TRAP80, Thyroid hormone receptor-associated protein complex 80 kDa component, Transcriptional coactivator CRSP77, Vitamin D3 receptor-interacting protein complex 80 kDa component
    Poids moléculaire
    72890 Da
    ID gène
    9440
    NCBI Accession
    NP_004259
    Pathways
    Intracellular Steroid Hormone Receptor Signaling Pathway, Stem Cell Maintenance, Regulation of Lipid Metabolism by PPARalpha
Vous êtes ici:
Support technique